Items where authors include "Barton, G."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Bacalja, A. orcid.org/0000-0002-2440-1488, Nichols, T.P. orcid.org/0000-0002-8648-1276, Robinson, B. orcid.org/0000-0002-2983-0206 et al. (28 more authors) (2024) Postdigital videogames literacies: thinking with, through, and beyond James Gee’s learning principles. Postdigital Science and Education, 6 (4). pp. 1103-1142. ISSN 2524-485X

Blackstone, J., Williams, T., Nicholas, J.M. et al. (59 more authors) (2024) Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open, 14 (9). e086414. ISSN 2044-6055

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Wailoo, A. orcid.org/0000-0002-9324-1617, Alava, M.H. orcid.org/0000-0003-4474-5883, Pudney, S. orcid.org/0000-0002-5697-0976 et al. (6 more authors) (2021) An international comparison of EQ-5D-5L and EQ-5D-3L for use in cost-effectiveness analysis. Value in Health, 24 (4). pp. 568-574. ISSN 1098-3015

Kolias, A.G., Edlmann, E., Thelin, E.P. et al. (26 more authors) (2018) Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial. Trials, 19. 670. ISSN 1745-6215

Hernandez Alava, M., Wailoo, A. orcid.org/0000-0002-9324-1617, Grimm, S. et al. (7 more authors) (2018) EQ-5D-5L versus EQ-5D-3L: the impact on cost-effectiveness in the United Kingdom. Value in Health, 21 (1). pp. 49-56. ISSN 1098-3015

Macran, S., Wileman, S., Barton, G. et al. (1 more author) (2007) The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: the Reflux questionnaire. Quality of Life Research, 16 (2). pp. 331-343. ISSN 0962-9343

Monograph

Hernandez Alava, M., Wailoo, A.J. orcid.org/0000-0002-9324-1617, Grimm, S. et al. (7 more authors) (2017) EQ-5D-5L versus 3L: the impact on cost-effectiveness. Report. ScHARR HEDS Discussion Papers . School of Health and Related Research , University of Sheffield.